Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL476017 | 0.80 | NR1H3 (0.45) | CES2CA12CA1CA2CA7 | |
| SCHEMBL18130040 | 0.79 | TYR (0.44) | CES2CA12CA1CA2CA7 | |
| SCHEMBL3246072 | 0.78 | CXCR1 (0.31) | — | |
| SCHEMBL10650840 | 0.76 | HSD17B10 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3810952 | 0.76 | ESR1 (0.41) | ESR1ESR2 | |
| SCHEMBL3718633 | 0.76 | ALDH1A1 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8333206 | 0.76 | HSD17B10 (0.50) | CA1CA2ALDH1A1TSHRALOX5 | |
| SCHEMBL6364905 | 0.76 | TRPA1 (0.52) | ALDH1A1GAAALOX15MEN1KMT2A | |
| SCHEMBL4259409 | 0.76 | CYP1A2 (0.45) | CA9TSHRALOX15MEN1KMT2A | |
| SCHEMBL910364 | 0.76 | NPC1 (0.53) | ALDH1A1TYRGAAALOX15MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| EP-3549574-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH OR HAIR RESTORATION, CONTAINING NOVEL PANTETHEINE-BASED SUBSTANCE | Korea Institute of Ocean Science & Technology (KR) | 2019-10-09 | — | — | EP | claimed |
| US-20190269593-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH CONTAINING NOVEL PANTETHEINE DERIVATIVE | KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) | 2019-09-05 | — | — | US | claimed |
| US-10376453-B1 | Composition for promoting hair growth containing novel pantetheine derivative | KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) | 2019-08-13 | — | — | US | claimed |
| CN-108529992-A | A kind of high-Miller-index surface and preparation method thereof | 济南大学 | 2018-09-14 | — | — | CN | claimed |
| US-20180185257-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH CONTAINING NOVEL PANTETHEINE DERIVATIVE | KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) | 2018-07-05 | — | — | US | claimed |
| WO-2018101502-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH OR HAIR RESTORATION, CONTAINING NOVEL PANTETHEINE-BASED SUBSTANCE | 한국해양과학기술원 | 2018-06-07 | — | — | WO | claimed |
| CN-106834268-A | It is a kind of based on the diatomaceous functional material for fixing polycyclic aromatic hydrocarbon-degrading bacteria | 光合强化（北京）生物科技有限公司 | 2017-06-13 | — | — | CN | claimed |
| EP-0929574-A1 | MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | Praecis Pharmaceuticals Incorporated (US) | 1999-07-21 | — | — | EP | claimed |
| EP-0923734-A1 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | Trega Biosciences, Inc. (US) | 1999-06-23 | — | — | EP | claimed |
| WO-1999003843-A1 | POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1999-01-28 | — | — | WO | claimed |
| US-5840500-A | OPIOD RECEPTORS AS ANALGESICS AND CENTRALLY ACTING PAIN KILLERS | TREGA BIOSCIENCES, INC. (US) | 1998-11-24 | — | — | US | claimed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998034111-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998008868-A9 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | — | 1998-05-28 | — | — | WO | claimed |
| WO-1998002741-A9 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | — | 1998-05-22 | — | — | WO | claimed |
| WO-1998008868-A1 | MODULATORS OF β-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS | PRAECIS PHARMACEUTICALS INCORPORATED (US) | 1998-03-05 | — | — | WO | claimed |
| WO-1998002741-A1 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-01-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10376453-B1 | Composition for promoting hair growth containing novel pantetheine derivative | FGF1, HPGD, FGF2 | CES2 4693/4885CA12 3292/4885CA1 3730/4885 |
| US-20180185257-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH CONTAINING NOVEL PANTETHEINE DERIVATIVE | EBP, HEXB, HDGF | CES2 4020/4885CA12 3384/4885CA1 3613/4885 |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | CES2 726/4885CA12 819/4885CA1 666/4885 |
| US-20190269593-A1 | COMPOSITION FOR PROMOTING HAIR GROWTH CONTAINING NOVEL PANTETHEINE DERIVATIVE | FGF1, HPGD, HDGF | CES2 4694/4885CA12 3442/4885CA1 3977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.